Jens Wrammert, PhD
Children’s Center for Immunology and Vaccines
An emerging leader in the analysis of human B cell responses following infection or vaccination. While in the Ahmed laboratory, he pioneered the use of plasmablast quantitation and sorting for the measurement of plasmablast responses and for the production of monoclonal antibodies representing early B cell responses. He has applied this to cloning of H1N1 influenza monoclonals and more recently to dengue virus monoclonals. He is now developing plasmablast technology for primate models of SIV/HIV pathogenesis.